What are alternative myeloma therapies for patients who are unable to afford lenalidomide or oral cyclophosphamide due to gaps in prescription drug coverage?
Several patients with inability to access oral cyclophosphamide or lenalidomide, have attempted assistance and grants to no avail.
1 Answer
Mednet MemberInvited Expert
Medical Oncology · OhioHealth
Answered on
Unfortunately, this is a big problem, especially in community centers where the resources for grant applications are scarce. At bigger institutions, like ours, we have a dedicated person who searches for all possible grants. If unable to, then the pharma companies have been generous to give free drugs- BMS especially.
For cytoxan, yes, copay can be very high for Medicare patients. I tend to give cytoxan IV for many of our Medicare patients.
So regimens that can be given in the clinic/infusion if oral meds are not an option:
- Daratumumab/velcade/cytoxan (IV, same dose as you would PO)/dex - I use this combination the most in these cases
- Daratumaba/cytoxan/dex
- Carfilzomib/cytoxan/dex
- Velcade/cytoxan/dex
- Dara or isatiximab/carfilzomib/dex
Any...
Join for free or sign in to see the full answer